The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of GRAB, IBM and AUPH

The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff

Grab Holdings Limited (NASDAQ:GRAB)
Class Period: November 12, 2021 - March 2, 2022
Lead Plaintiff Deadline: May 16, 2022

The complaint alleges that throughout the class period Grab Holdings Limited made materially false and/or misleading statements and/or failed to disclose that: (1) Grab's driver supply declined during the third quarter; (2) as a result, Grab continued to invest heavily in driver and consumer incentives to "preemptively recalibrate driver supply"; (3) as a result, the Company's financial results would be adversely impacted, including, among other things, a significant decline in revenue; and (4) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects were materially
misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in GRAB: https://www.kleinstocklaw.com/pslra-1/grab-holdings-limited-loss-submission-form?id=26428&from=1

International Business Machines Corporation (NYSE:IBM)
Class Period: April 4, 2017 - October 20, 2021
Lead Plaintiff Deadline: June 6, 2022

According to the complaint, International Business Machines Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Strategic Imperatives Revenue and growth, CAMSS and CAMSS Components' revenue and growth, and the Company's Segments' revenue and growth were artificially inflated as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives Revenue; (ii) the Company's present success and positive future growth prospects concerning its Strategic Imperative business strategy were being fueled by the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperative Revenue and, as a result (iii) the Company misled the market by portraying the Company's Strategic Imperative's financial performance and future prospects more favorable than they actually were as a result of the wrongful reclassification of revenues from non-strategic to strategic to make those revenues eligible for treatment as Strategic Imperatives.

Learn about your recoverable losses in IBM: https://www.kleinstocklaw.com/pslra-1/international-business-machines-corporation-loss-submission-form?id=26428&from=1

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)
Class Period: May 7, 2021 - February 25, 2022
Lead Plaintiff Deadline: June 14, 2022

The AUPH lawsuit alleges Aurinia Pharmaceuticals Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (i) Aurinia was experiencing declining revenues; (ii) Aurinia's 2022 sales outlook for the Company's only product which it offers for the treatment of adult patients with active lupus nephritis, LUPKYNIS, would fall well short of expectations; (iii) accordingly, the Company had significantly overstated LUPKYNIS's commercial prospects; (iv) as a result, the Company had overstated its financial position and/or prospects for 2022; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in AUPH: https://www.kleinstocklaw.com/pslra-1/aurinia-pharmaceuticals-inc-loss-submission-form?id=26428&from=1

The Klein Law Firm, Wednesday, April 27, 2022, Press release picture

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE : The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/699089/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-GRAB-IBM-and-AUPH

News Provided by ACCESSWIRE IA via QuoteMedia

AUP:CA,AUPH
The Conversation (0)
Cizzle Brands Chairman and CEO John Celenza.

Looming US-Canada Tariff War “No Effect” on Cizzle Brands' Operations, CEO Says

Amid a looming trade conflict between the US and Canada, Cizzle Brands (CBOE:CIZZL) Chairman and CEO John Celenza has assured the investor community that potential tariffs will have no impact on operations.

“We have manufacturing on both sides of the border (and) warehousing on both sides of the border. We have a Canadian corp and a US corp, so we're set up perfectly fine. It won't have any effect on us,” he said.

Cizzle Brands is a health and wellness food and beverage company.

Keep reading...Show less
Cizzle Brands Secures Distribution for CWENCH Hydration at MacEwen-Owned Gas Stations in Ontario and Quebec

Cizzle Brands Secures Distribution for CWENCH Hydration at MacEwen-Owned Gas Stations in Ontario and Quebec

The availability of CWENCH Hydration at 54 MacEwen-owned Esso , Shell , MacEwen and Quickie gas stations is a direct result of the recently announced distribution agreement between Cizzle Brands Corporation and Keurig Dr Pepper Canada subsidiary Van Houtte Coffee Services ("VHCS"), which distributes to over 30,000 commercial sites across Canada. This agreement with VHCS has already yielded meaningful results in helping to commercialize CWENCH Hydration™.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

Amgen (NASDAQ: AMGN) will present at the 35 th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m. ET on Wednesday Feb. 12, 2025. Narimon Honarpour, senior vice president of global development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE

Amgen (NASDAQ: AMGN) will present at the 35 th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m. ET on Wednesday Feb. 12, 2025. Narimon Honarpour, senior vice president of global development at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.

The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less
Cizzle Brands Corporation Becomes Title Sponsor of the CWENCH All Canadian Volleyball Games

Cizzle Brands Corporation Becomes Title Sponsor of the CWENCH All Canadian Volleyball Games

Entering its third year, the CWENCH All Canadian Volleyball Games is Canada's premier girls' volleyball event. Set to take the national stage with live streaming on CBC Gem, the event features 60 of Canada's top-performing girls' volleyball players in each of the 17U and 16U age categories. As a proudly Canadian house of brands, this sponsorship is part of Cizzle Brands' ongoing initiatives to support youth sports in Canada.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×